{"product_id":"neuehealth-swot-analysis","title":"NeueHealth SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDive Deeper Into the Company’s Strategic Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eNeueHealth's strengths lie in its innovative approach to healthcare delivery and its strong market presence. However, understanding the full picture of its competitive landscape, potential threats, and untapped opportunities is crucial for strategic advantage.\u003c\/p\u003e\n\u003cp\u003eWant the full story behind NeueHealth’s strengths, risks, and growth drivers? Purchase the complete SWOT analysis to gain access to a professionally written, fully editable report designed to support planning, pitches, and research.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Technology and Data Platform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNeueHealth's proprietary technology, exemplified by its NewPulse platform, is a significant strength. This integrated system streamlines both care delivery and administrative processes, a crucial advantage in the complex healthcare landscape.\u003c\/p\u003e\n\u003cp\u003eThe platform's core function is to align financial incentives with the actual delivery of care, a strategic move designed to bypass traditional bottlenecks like pre-authorizations. This efficiency gain is key to their operational model.\u003c\/p\u003e\n\u003cp\u003eNeueHealth's commitment to this technology underpins its ambitious growth strategy, aiming to fundamentally improve the healthcare experience for everyone involved – patients, doctors, and insurance providers alike.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Focus on Value-Based Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNeueHealth's core strength lies in its unwavering commitment to a value-based care model. This consumer-centric approach harmonizes the goals of patients, healthcare providers, and insurance payers, aiming for better health results and lower costs.\u003c\/p\u003e\n\u003cp\u003eThe company's consistent messaging and reported financial performance throughout 2024 and into 2025 highlight the effectiveness and growing adoption of this patient-first strategy. This focus is a key differentiator in a rapidly evolving healthcare landscape.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsistent Adjusted EBITDA Profitability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNeueHealth has shown impressive operational efficiency, maintaining positive Adjusted EBITDA for six consecutive quarters through the second quarter of 2025. This consistent profitability highlights the company's ability to manage costs effectively and generate solid earnings from its core operations.\u003c\/p\u003e\n\u003cp\u003eThis sustained positive Adjusted EBITDA trend, reaching six consecutive quarters by Q2 2025, underscores a robust financial foundation and improved underlying business performance. It signals a healthy operational engine capable of supporting future strategic initiatives and growth ambitions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSignificant Consumer Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNeueHealth has seen impressive expansion in its consumer base, a clear indicator of its growing market presence. This significant growth is directly tied to the increasing adoption of their healthcare model.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsumer Base Expansion:\u003c\/strong\u003e NeueHealth served approximately 717,000 consumers at the beginning of 2025, marking a substantial 48% increase from the previous year.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContinued Q1 Growth:\u003c\/strong\u003e The company maintained this upward trajectory into the first quarter of 2025, reaching 709,000 consumers, a 51% jump compared to Q1 2024.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQ2 Momentum:\u003c\/strong\u003e This positive trend continued into the second quarter of 2025, with 694,000 consumers, representing a 45% year-over-year increase.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad Market Appeal:\u003c\/strong\u003e The company's success spans across the Affordable Care Act (ACA) Marketplace, Medicare, and Medicaid populations, demonstrating strong market acceptance of their care delivery approach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Care and Provider Enablement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNeueHealth's integrated care model is a significant strength, blending its own clinical services with health plan administration and provider support. This synergy allows for highly coordinated patient care and empowers independent doctors.  By partnering with over 3,000 affiliated providers, NeueHealth significantly expands its network and influence in the healthcare landscape.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue-Based Care Drives Robust Growth and Financial Strength\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNeueHealth's proprietary technology, particularly its NewPulse platform, is a core strength, streamlining care delivery and administrative tasks. This platform aligns financial incentives with actual care, bypassing traditional hurdles like pre-authorizations, which enhances operational efficiency.\u003c\/p\u003e\n\u003cp\u003eThe company's commitment to a value-based care model, focusing on consumer-centricity, harmonizes the objectives of patients, providers, and payers for improved outcomes and cost reduction. This patient-first strategy is a key differentiator, evidenced by consistent positive financial performance throughout 2024 and into 2025.\u003c\/p\u003e\n\u003cp\u003eNeueHealth has demonstrated robust financial health, achieving positive Adjusted EBITDA for six consecutive quarters through Q2 2025, underscoring effective cost management and strong operational earnings. This consistent profitability provides a solid foundation for future growth and strategic initiatives.\u003c\/p\u003e\n\u003cp\u003eThe company's consumer base has expanded significantly, reflecting growing market acceptance of its healthcare model. This growth is evident across various market segments, including the ACA Marketplace, Medicare, and Medicaid.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eQ1 2024\u003c\/th\u003e\n\u003cth\u003eQ1 2025\u003c\/th\u003e\n\u003cth\u003eQ2 2025\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumers Served\u003c\/td\u003e\n\u003ctd\u003eApprox. 470,000\u003c\/td\u003e\n\u003ctd\u003e709,000\u003c\/td\u003e\n\u003ctd\u003e694,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYear-over-Year Consumer Growth\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e51%\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsecutive Quarters of Positive Adj. EBITDA\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a strategic overview of NeueHealth’s internal and external business factors, highlighting its competitive position and market challenges.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOffers a clear, actionable framework to identify and address market challenges, transforming potential weaknesses into strategic advantages.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInconsistent Revenue Performance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite a growing consumer base, NeueHealth has faced challenges with inconsistent revenue. Consolidated revenue saw a dip in recent periods, with Q1 2025 revenue reported at $215.8 million, down from $245.1 million in Q1 2024. This trend continued with Q4 2024 also experiencing a year-over-year revenue decline.\u003c\/p\u003e\n\u003cp\u003eThis mixed revenue performance could indicate issues with revenue generated per consumer or a shift in the membership composition that is hindering overall top-line growth. Understanding these dynamics is crucial for forecasting future financial performance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNYSE Non-Compliance and Financial Vulnerability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNeueHealth faces significant headwinds due to its non-compliance with NYSE listing requirements, as evidenced by the June 2024 notice concerning market capitalization and stockholders' equity. This notification signals underlying financial fragility and raises concerns about the company's ability to meet ongoing public trading standards.\u003c\/p\u003e\n\u003cp\u003eThe ongoing efforts to rectify this situation are crucial, as failure to regain compliance could lead to delisting, severely impacting liquidity and investor confidence. For instance, a company's market capitalization falling below $50 million for an extended period can trigger delisting procedures on major exchanges.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReliance on External Capital Infusion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNeueHealth's reliance on external capital remains a key weakness. The company successfully raised $30 million in April 2024, with NEA notably increasing its stake, highlighting the ongoing need for significant funding. This repeated requirement for investor capital suggests potential liquidity constraints or substantial ongoing operational expenses that are not yet self-sustaining.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePersistent Net Losses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNeueHealth faces a significant weakness in its persistent net losses, even with improvements in adjusted EBITDA. For instance, the company reported a net loss of $10.8 million in the first quarter of 2025. This follows a substantial net loss from continuing operations of $42.48 million in the fourth quarter of 2024.\u003c\/p\u003e\n\u003cp\u003eThese figures highlight that while operational performance may be improving, other financial factors are preventing the company from achieving overall profitability. Non-operating expenses, interest payments, or other significant costs are clearly impacting the bottom line, posing a challenge to the company's financial health.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersistent Net Losses:\u003c\/strong\u003e Despite positive Adjusted EBITDA, net losses continue.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQ1 2025 Net Loss:\u003c\/strong\u003e The company reported a net loss of $10.8 million in Q1 2025.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQ4 2024 Net Loss:\u003c\/strong\u003e A net loss from continuing operations of $42.48 million was recorded in Q4 2024.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImpact of Non-Operating Expenses:\u003c\/strong\u003e These losses indicate significant impacts from interest, non-operating expenses, or other financial factors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational Challenges of Going Private\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNeueHealth's anticipated move to go private by mid-to-late 2025, while strategically advantageous, introduces significant operational hurdles. The intricacies of delisting and subsequent restructuring can divert crucial management attention away from day-to-day business activities. This transition demands careful navigation to avoid disruptions.\u003c\/p\u003e\n\u003cp\u003eThe execution of this privatization carries inherent risks, particularly in ensuring a seamless transition that maximizes shareholder value. Potential disruptions to supply chains or customer relations during this period are a concern. For instance, during the privatization of Dell in 2013, the company faced a period of uncertainty that impacted its market perception, although it ultimately benefited from the private structure.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eManagement Focus Diversion:\u003c\/strong\u003e The substantial effort required for privatization can pull key personnel away from core business functions, potentially impacting innovation or customer service.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExecution Risk:\u003c\/strong\u003e Ensuring a smooth transition without significant operational disruptions or loss of key talent is a complex undertaking with no guaranteed outcome.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntegration Complexity:\u003c\/strong\u003e If restructuring involves integrating new private equity ownership or operational changes, the complexity of these processes can exacerbate challenges.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePersistent Losses \u0026amp; Compliance Woes Challenge Financial Stability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNeueHealth's financial performance shows a concerning trend of persistent net losses, even when adjusted EBITDA shows improvement. The company reported a net loss of $10.8 million in the first quarter of 2025, following a significant net loss from continuing operations of $42.48 million in the fourth quarter of 2024. These figures underscore that factors beyond core operations, such as non-operating expenses or interest payments, are substantially impacting the company's overall profitability and financial health.\u003c\/p\u003e\n\u003cp\u003eThe company is also facing significant challenges related to its compliance with NYSE listing requirements. A notice issued in June 2024 highlighted issues with market capitalization and stockholders' equity, indicating underlying financial fragility. Failure to regain compliance could lead to delisting, which would severely impact liquidity and investor confidence, a risk amplified by market capitalization falling below $50 million for extended periods on major exchanges.\u003c\/p\u003e\n\u003cp\u003eNeueHealth's reliance on external capital remains a notable weakness, evidenced by a $30 million capital raise in April 2024 where NEA increased its stake. This ongoing need for substantial funding suggests potential liquidity constraints or significant ongoing operational expenses that are not yet self-sustaining, posing a challenge to its financial independence.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eFinancial Metric\u003c\/th\u003e\n\u003cth\u003eQ4 2024\u003c\/th\u003e\n\u003cth\u003eQ1 2025\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eDeclined year-over-year\u003c\/td\u003e\n\u003ctd\u003e$215.8 million (down from $245.1 million in Q1 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Loss\u003c\/td\u003e\n\u003ctd\u003e$42.48 million (from continuing operations)\u003c\/td\u003e\n\u003ctd\u003e$10.8 million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNYSE Compliance\u003c\/td\u003e\n\u003ctd\u003eReceived non-compliance notice (June 2024)\u003c\/td\u003e\n\u003ctd\u003eOngoing efforts to regain compliance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapital Raised\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e$30 million (April 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eNeueHealth SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview reflects the real document you'll receive—professional, structured, and ready to use. You're seeing the actual NeueHealth SWOT analysis, ensuring transparency and quality. Once purchased, you'll gain full access to this comprehensive report.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55673873432953,"sku":"neuehealth-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/neuehealth-swot-analysis.png?v=1755784024","url":"https:\/\/portersfiveforce.com\/products\/neuehealth-swot-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}